Lung cancer drug Lilly bought for $8 billion delivers strong results - STAT

Lung cancer drug Lilly bought for $8 billion delivers strong results - STAT

STAT Plus: Lung cancer drug Lilly bought for $8 billion delivers strong results

By MATTHEW HERPER

ANNE WESTON/FRANCIS CRICK INSTITUTE/WELLCOME

The drug, delievered by Loxo Oncology, was shown in a clinical trial to be effective in lung cancer patients with a specific gene alteration.

READ MORE